PAC-LINK Bio Management

Pac-Link Management is a venture capital firm headquartered in Taipei, Taiwan, specializing in early- and late-stage investments within the biotechnology, healthcare, and information technology sectors. Established in 1998, the firm has managed multiple funds with a total capital commitment reaching over $400 million at its peak. Pac-Link is known for its cross-border investment strategy, frequently participating in financing rounds for North American life science companies such as Revance Therapeutics, Serenex, and Bayhill Therapeutics. The firm aims to foster growth and operational efficiency by leveraging its extensive industrial network and expertise in the Asian and Western markets. While historically a significant player in the biotech investment landscape, the firm is currently considered inactive in terms of new deal flow.